Cargando…
Pentraxin-3 in Thrombolytic Therapy for Acute Ischemic Stroke: No Relation with Curative Effect and Prognosis
BACKGROUND: Pentraxin-3 (PTX3) is considered a high quality inflammatory marker of the severity and prognosis of several diseases, however, the value of PTX3 in thrombolytic therapy for acute ischemic stroke remains unclear and PTX3 is still controversial in evaluating the prognosis of stroke patien...
Autores principales: | Zhang, Chun-Yang, Han, He-Dong, Wang, Si-Yang, Huang, Shi-Ren, Deng, Ben-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052828/ https://www.ncbi.nlm.nih.gov/pubmed/29949524 http://dx.doi.org/10.12659/MSM.909015 |
Ejemplares similares
-
Improper Use of Thrombolytic Agents in Acute Hemiparesis Following Misdiagnosis of Acute Ischemic Stroke
por: Kim, Min Chan, et al.
Publicado: (2018) -
Mean Platelet Volume, C-Reactive Protein, and Prognosis in Patients with Acute Ischemic Stroke Following Intravenous Thrombolytic Treatment
por: İnanç, Yusuf, et al.
Publicado: (2018) -
Effect of Intravenous Thrombolytic Dose of Alteplase on Long-Term Prognosis in Patients with Acute Ischemic Stroke
por: Zhai, Mingfeng, et al.
Publicado: (2023) -
Intravenous Thrombolytics in the Treatment of Acute Ischemic Stroke
por: Alhadid, Kenda, et al.
Publicado: (2023) -
Susceptibility-weighted Imaging in Thrombolytic Therapy of Acute Ischemic Stroke
por: Li, Lin, et al.
Publicado: (2017)